Arguing that the benefits of the vaccine "Far outweigh the risks" from expedited approval, British regulator MHRA - Medicines and Healthcare products Regulatory Agency - has become the first in the West to approve the Pfizer-BioNTech vaccine for emergency use, a landmark decision that has once again lifted the market's mood as the never-ending procession of vaccine news continues.
Now, the UK, which has been testing large-scale delivery systems for the vaccine will be the first in the West to test its logistical prowess as regulators in the US and Brussels scramble to catch up.
Distribution of the vaccine in the UK will start on Monday.
The benefits of the Pfizer/BioNTech vaccine "Far outweigh any risk", says Dr June Raine from UK regulator MHRA. In terms of other Covid vaccines, "Further rolling reviews" are ongoing https://t.
"I consider this decision to be problematic and recommend that EU Member States do not repeat the process in the same way. A few weeks of thorough examination by the European Medicines Agency is better than a hasty emergency marketing authorisation of a vaccine," said Peter Liese, an EU lawmaker who is a member of German Chancellor Angela Merkel's party.
Analyst Graham Doyle warned that there are risks to approving the vaccine so early without a thorough review, though he added that while the development is "Theoretically positive" for the fight against the virus in UK, he expects the AstraZeneca vaccine to be ultimately more important given its "Scale, price and logistical advantages."
To be sure, China and Russia have already granted emergency use authorization for vaccines developed domestically, and China is believed to have already vaccinated more than 1 million people.
Wednesday, December 2, 2020
"The Benefits Far Outweigh The Risks" - Pfizer COVID Vaccine Wins UK Approval
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment